Überla K - Search Results

1

Propagation of SARS-CoV-2 in a Closed Cell Culture Device: Potential GMP Compatible Production Platform for Live-Attenuated Vaccine Candidates under BSL-3 Conditions?

Klessing S, Peter AS, Fraedrich K, Wagner JT, Kummer M, Deutschmann J, Steininger P, Steibl HD, Überla K. Klessing S, et al. Among authors: uberla k. Viruses. 2023 Jan 30;15(2):397. doi: 10.3390/v15020397. Viruses. 2023. PMID: 36851610 Free PMC article.

2

Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay.

Nagel A, Dimitrakopoulou E, Teig N, Kern P, Lücke T, Michna D, Korn K, Steininger P, Shahada K, Neumann K, Überla K. Nagel A, et al. Among authors: uberla k. PLoS One. 2020 Jan 9;15(1):e0227143. doi: 10.1371/journal.pone.0227143. eCollection 2020. PLoS One. 2020. PMID: 31917817 Free PMC article.

3

Modulation of Vaccine-Induced HIV-1-Specific Immune Responses by Co-Electroporation of PD-L1 Encoding DNA.

Tannig P, Peter AS, Lapuente D, Klessing S, Damm D, Tenbusch M, Überla K, Temchura V. Tannig P, et al. Among authors: uberla k. Vaccines (Basel). 2020 Jan 14;8(1):27. doi: 10.3390/vaccines8010027. Vaccines (Basel). 2020. PMID: 31947643 Free PMC article.

4

Genetic Co-Administration of Soluble PD-1 Ectodomains Modifies Immune Responses against Influenza A Virus Induced by DNA Vaccination.

Tannig P, Peter AS, Lapuente D, Klessing S, Schmidt A, Damm D, Tenbusch M, Überla K, Temchura V. Tannig P, et al. Among authors: uberla k. Vaccines (Basel). 2020 Oct 1;8(4):570. doi: 10.3390/vaccines8040570. Vaccines (Basel). 2020. PMID: 33019546 Free PMC article.

5

CD4⁺ T Cells Induced by Tuberculosis Subunit Vaccine H1 Can Improve the HIV-1 Env Humoral Response by Intrastructural Help.

Klessing S, Temchura V, Tannig P, Peter AS, Christensen D, Lang R, Überla K. Klessing S, et al. Among authors: uberla k. Vaccines (Basel). 2020 Oct 13;8(4):604. doi: 10.3390/vaccines8040604. Vaccines (Basel). 2020. PMID: 33066267 Free PMC article.

6

Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2.

Lapuente D, Maier C, Irrgang P, Hübner J, Peter AS, Hoffmann M, Ensser A, Ziegler K, Winkler TH, Birkholz T, Kremer AE, Steininger P, Korn K, Neipel F, Überla K, Tenbusch M. Lapuente D, et al. Among authors: uberla k. Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):751-759. doi: 10.1007/s10096-020-04072-7. Epub 2020 Oct 20. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33078221 Free PMC article.

7

Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients.

Strasser EF, Steininger PA, Korn K, Achenbach S, Tenbusch M, Cunningham S, Zimmermann R, Überla K, Hackstein H. Strasser EF, et al. Among authors: uberla k. Transfusion. 2021 Feb;61(2):368-374. doi: 10.1111/trf.16178. Epub 2020 Nov 9. Transfusion. 2021. PMID: 33125162

8

IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.

Hahn F, Wangen C, Häge S, Peter AS, Dobler G, Hurst B, Julander J, Fuchs J, Ruzsics Z, Überla K, Jäck HM, Ptak R, Muehler A, Gröppel M, Vitt D, Peelen E, Kohlhof H, Marschall M. Hahn F, et al. Among authors: uberla k. Viruses. 2020 Dec 5;12(12):1394. doi: 10.3390/v12121394. Viruses. 2020. PMID: 33291455 Free PMC article.

9

Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020.

Wagner R, Peterhoff D, Beileke S, Günther F, Berr M, Einhauser S, Schütz A, Niller HH, Steininger P, Knöll A, Tenbusch M, Maier C, Korn K, Stark KJ, Gessner A, Burkhardt R, Kabesch M, Schedl H, Küchenhoff H, Pfahlberg AB, Heid IM, Gefeller O, Überla K. Wagner R, et al. Among authors: uberla k. Viruses. 2021 Jun 10;13(6):1118. doi: 10.3390/v13061118. Viruses. 2021. PMID: 34200766 Free PMC article.

10

Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.

Tenbusch M, Schumacher S, Vogel E, Priller A, Held J, Steininger P, Beileke S, Irrgang P, Brockhoff R, Salmanton-García J, Tinnefeld K, Mijocevic H, Schober K, Bogdan C, Yazici S, Knolle P, Cornely OA, Überla K, Protzer U; DZIF-VACCELERATE-CoVaKo study team. Tenbusch M, et al. Among authors: uberla k. Lancet Infect Dis. 2021 Sep;21(9):1212-1213. doi: 10.1016/S1473-3099(21)00420-5. Epub 2021 Jul 29. Lancet Infect Dis. 2021. PMID: 34332707 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

289 results

Search Page